# Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

> **NCT01803451** · EARLY_PHASE1 · RECRUITING · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 80 (estimated)

## Conditions studied

- Post-bariatric Surgery

## Interventions

- **DRUG:** exendin-(9-39)
- **DRUG:** exendin -(9-39)

## Key facts

- **NCT ID:** NCT01803451
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2005-11
- **Primary completion:** 2026-08
- **Final completion:** 2027-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01803451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01803451, "Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01803451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*